DNDi Drugs for Neglected Diseases initiative

Activities: Research & Development

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  4. Effective ways to optimise heat exchangers Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
  5. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...

Upcoming event

Lounges

23-25 April 2024 | Conference | Messe Karlsruhe, Germany See all

Related Content

Research & Development

Bayer and DNDi to develop oral treatment for human river blindness

German healthcare giant will provide active ingredient emodepside which shows potential as a macrofilaricidal drug
Research & Development

Old drug shows new promise to treat leishmaniasis

University of Dundee scientists study fexinidazole
Research & Development

Drug companies join forces to end neglected tropical diseases

Will expand drug donation programmes and provide US$785m to support r&d efforts
Research & Development

Sanofi and DNDi sign research collaboration deal

To generate new drugs for Neglected Tropical Diseases
Regulatory

Pfizer and DNDi enter tropical disease partnership

To support the development of improved treatments for neglected African diseases
Sustainability

Consortium to develop drugs for neglected tropical diseases

<p>A consortium has been formed to develop drugs for the treatment of African sleeping sickness and Leishmaniasis, which affect millions of people worldwide. </p>
Research & Development

Merck & Co and DNDi collaborate to find treatments for world's most neglected tropical diseases

To develop improved treatments for NTDs such as visceral leishmaniasis and Chagas disease
Subscribe now